FR2391728A1 - Application pharmacologique de cephalosporines - Google Patents

Application pharmacologique de cephalosporines

Info

Publication number
FR2391728A1
FR2391728A1 FR7825299A FR7825299A FR2391728A1 FR 2391728 A1 FR2391728 A1 FR 2391728A1 FR 7825299 A FR7825299 A FR 7825299A FR 7825299 A FR7825299 A FR 7825299A FR 2391728 A1 FR2391728 A1 FR 2391728A1
Authority
FR
France
Prior art keywords
cephalosporins
pharmacological application
pharmacological
esters
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7825299A
Other languages
English (en)
Other versions
FR2391728B1 (fr
Inventor
Lee Cannon Cheney
Charles Truman Holdrege
Stephen Richard Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2391728A1 publication Critical patent/FR2391728A1/fr
Application granted granted Critical
Publication of FR2391728B1 publication Critical patent/FR2391728B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet l'application pharmacologique de céphalosporines nouvelles. Elle se rapporte à l'application pharmacologique des composés de formule générale 1, à leurs esters aisément dissociables et aux sels pharmaceutiquement acceptables de ces esters ou de ces composés de formule :
FR7825299A 1973-01-31 1978-09-01 Application pharmacologique de cephalosporines Granted FR2391728A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32823473A 1973-01-31 1973-01-31
US36169673A 1973-05-18 1973-05-18

Publications (2)

Publication Number Publication Date
FR2391728A1 true FR2391728A1 (fr) 1978-12-22
FR2391728B1 FR2391728B1 (fr) 1982-08-20

Family

ID=26986279

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7403339A Expired FR2215942B1 (fr) 1973-01-31 1974-01-31
FR7825299A Granted FR2391728A1 (fr) 1973-01-31 1978-09-01 Application pharmacologique de cephalosporines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7403339A Expired FR2215942B1 (fr) 1973-01-31 1974-01-31

Country Status (7)

Country Link
JP (1) JPS5953275B2 (fr)
CA (1) CA1035353A (fr)
DE (1) DE2404592C2 (fr)
FR (2) FR2215942B1 (fr)
GB (1) GB1439419A (fr)
NL (1) NL7401361A (fr)
PH (2) PH16419A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL49183A0 (en) * 1975-03-27 1976-05-31 Pfizer Novel cephalosporin derivatives,their preparation and pharmaceutical compositions containing them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915169D0 (pt) * 1969-04-21 1973-02-20 Bristol Myers Co Processo quimico
NL7112483A (fr) * 1970-09-14 1972-03-16
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
YU36967B (en) * 1971-01-18 1984-08-31 Bristol Myers Co Process for the production of antibacterial agents
US3757014A (en) * 1971-05-07 1973-09-04 Bristol Myers Co Ts 1,3,4 - oxadiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic acid and sal7-(d-(alpha-amino-alpha-pheyle-acetamido)) - 3-(s-(5-hydroxymethyl -
CA999574A (en) * 1972-06-14 1976-11-09 Smith Kline And French Canada Ltd. 7-hydroxyhalophenylacetamido-3-h heterocyclicthiomethyl cephalosporins
CA1076560A (fr) * 1972-06-14 1980-04-29 Smith Kline And French Canada Ltd. Thiomethylcephalosporines avec substitution en 3 par un compose heterocyclique

Also Published As

Publication number Publication date
NL7401361A (fr) 1974-08-02
PH14842A (en) 1981-12-16
FR2215942A1 (fr) 1974-08-30
FR2391728B1 (fr) 1982-08-20
CA1035353A (fr) 1978-07-25
JPS49101395A (fr) 1974-09-25
DE2404592A1 (de) 1974-08-01
FR2215942B1 (fr) 1978-12-22
DE2404592C2 (de) 1984-01-19
JPS5953275B2 (ja) 1984-12-24
GB1439419A (en) 1976-06-16
PH16419A (en) 1983-09-29

Similar Documents

Publication Publication Date Title
FR2389640A1 (fr)
FR2423221A1 (fr) Cycloalcoyltriazoles pharmaceutiquement utilisables et procedes pour leur obtention
FR2372810A1 (fr) Nouvelles aminoalcoylimidazolidinones, procedes pour leur preparation et leur utilisation en tant que medicaments
FR2360597A1 (fr) Malo-aluminates complexes utiles pour la prophylaxie des caries dentaires
FI864527A (fi) Tricyklofoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandning.
FR2383922A1 (fr) Nouvelles 4-acylamino-phenyl-ethanolamines, procede pour leur preparation et leur utilisation en tant que medicaments
FR2359144A1 (fr) Sels de l'acide clavulanique utilisable comme medicaments
FR2362170A1 (fr) Nouvelles polyurees
FR2390960A1 (fr) Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
FR2417504A1 (fr) Composes d'imidazole
FR2375239A1 (fr) Derives d'acide 7-amino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
FR2358890A1 (fr) Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2391728A1 (fr) Application pharmacologique de cephalosporines
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
ES371297A1 (es) Procedimiento para la obtencion de 4-ciano-4-fenil-aminoci-clohexanos.
FR2355847A1 (fr) Nouvelles cephalosporines
FR2374313A1 (fr) Compose a cycle triazole utilisable comme medicament
FR2400505A1 (fr) 1-phenylethanolamines anti-inflammatoires, compositions pharmaceutiques en comprenant et procedes pour les produire
FR2405948A1 (fr) Nouvelles 4-phenyl-thieno-(2,3-c)- piperidines, procedes pour leur preparation et compositions pharmaceutiques les renfermant
FR2380291A1 (fr) Sels d'imidazole-methylphosphonium, leur procede de preparation et leurs applications
ES8505375A1 (es) Un procedimiento para obtener esteres de cefalosporina
FR2415104A1 (fr) 6-alcoyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines et leurs applications en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse